Kampala 20 March 2025 – The Uganda Cancer Institute (UCI) continues to revolutionize cancer care in Uganda, making significant strides in treatment accessibility, cutting-edge research, and the expansion of state-of-the-art medical infrastructure. With new regional cancer centers, advanced treatment technologies, and pioneering research initiatives, UCI is setting new benchmarks in the fight against cancer.
Expanding Cancer Care Across Uganda:
Recognizing the need for accessible cancer care, UCI has established regional cancer centers across Uganda to bring life-saving services closer to communities. The fully operational UCI Gulu Regional Cancer Center now provides diagnostic, imaging, chemotherapy, and surgical services for northern Uganda. The Arua, Mbarara, and Mbale Regional Cancer Centers are set to begin construction in the 2025/26 fiscal year, ensuring that patients in western, eastern, and West Nile regions can access treatment without the burden of long-distance travel.
Revolutionizing Cancer Treatment with Advanced Technology:
UCI has introduced cutting-edge technologies, including Linear Accelerators (LINACs) for precise radiation therapy and Molecular Imaging and Therapy to enhance early cancer detection. The newly commissioned SPECT-CT scanner and the ongoing construction of a PET imaging facility will significantly improve diagnostic accuracy and treatment outcomes.
Additionally, UCI is leading in molecular therapy, a personalized treatment approach targeting the genetic profile of individual tumors. This advancement ensures more effective treatments with fewer side effects, reinforcing UCI’s role as a regional leader in precision oncology.
Modern Pathology and Diagnostic Laboratories:
State-of-the-art pathology labs at UCI are playing a crucial role in early cancer detection and treatment planning. These facilities support research into Uganda’s unique cancer burden, enabling genetic analysis that informs the development of targeted therapies. The integration of genomic medicine is paving the way for more effective, customized cancer treatments.
Advancing Pediatric Cancer Care:
UCI has made substantial progress in pediatric oncology, establishing a dedicated Pediatric Cancer Unit to cater to the unique needs of children with cancer. The unit offers specialized treatments, the latest chemotherapy protocols, and access to targeted therapies to improve outcomes while minimizing side effects. A pediatric cancer survivorship program has also been launched to provide long-term follow-up care for young survivors.
Driving National Cancer Control Strategies:
A key milestone in Uganda’s cancer fight is the implementation of the National Cancer Control Plan (NCCP), developed in 2024. This strategic framework focuses on cancer prevention, early detection, treatment, and palliative care. UCI has been instrumental in expanding screening programs, particularly for cervical and breast cancer, and promoting public awareness to reduce cancer incidence.
A Future of Hope and Innovation:
UCI’s relentless commitment to innovation, patient-c
Uganda Cancer Institute Expands Cancer Care with Groundbreaking Innovations
Kampala, Uganda – March 2025 – The Uganda Cancer Institute (UCI) is leading the charge against cancer in Uganda, making remarkable progress in treatment accessibility, cutting-edge research, and the expansion of state-of-the-art facilities. The institute’s recent milestones include the establishment of regional cancer centers, advanced treatment technologies, and pediatric cancer care innovations.
Expanding Cancer Care Across Uganda:
To bring life-saving services closer to communities, UCI is establishing regional cancer centers in Gulu, Arua, Mbarara, and Mbale. The Gulu Regional Cancer Center is already operational, offering diagnostics, imaging, chemotherapy, surgery, and palliative care. Construction for centers in Arua, Mbarara, and Mbale will commence in the 2025/26 fiscal year, significantly reducing travel distances for patients in these regions.
Advanced Treatment Technologies:
UCI has acquired Linear Accelerators (LINACs) for high-precision radiation therapy and is pioneering Molecular Imaging and Therapy, including a SPECT-CT scanner and an upcoming PET facility. These innovations enhance early cancer detection, ensuring timely and effective treatment. The institute is also advancing molecular therapy, a personalized treatment approach targeting the genetic profiles of individual tumors.
Cutting-Edge Diagnostic and Research Laboratories:
UCI’s investment in modern pathology labs is revolutionizing cancer diagnostics and research. These laboratories facilitate early cancer detection, support personalized treatment plans, and contribute to genomic research aimed at understanding Uganda’s unique cancer burden.
Advancements in Pediatric Cancer Care:
UCI has launched a Pediatric Oncology Unit, offering specialized treatments, the latest chemotherapy protocols, and targeted therapies for childhood cancers. The institute also runs a pediatric cancer survivorship program, ensuring long-term care and monitoring for young survivors.
National Cancer Control Plan (NCCP):
As a key player in Uganda’s National Cancer Control Plan (NCCP), UCI is driving efforts in cancer prevention, early detection, and public awareness. The plan includes expanded screening programs for cervical and breast cancer, helping reduce Uganda’s cancer burden.
A Brighter Future for Cancer Care:
With continued investments in infrastructure, technology, and research, UCI is reinforcing its position as a leader in cancer treatment in Uganda and across Africa. These groundbreaking initiatives are making cancer care more accessible, effective, and patient-centered, offering hope to countless individuals and families.
